Zydus Lifesciences gets USFDA nod to market generic drugs

Zydus Lifesciences has won regulatory clearance in the United States to launch generic Ivermectin and Dapsone tablets. Used to treat parasitic worm infections and leprosy, the approval signals progress in the company's US growth strategy and broadens its market footprint.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mQ4rfo7
via IFTTT